Correspondence Volume 121 | Issue 11-12 | Nov-Dec 2013
Environ Health Perspect; DOI:10.1289/ehp.1307424
Exposure Conditions and Pharmacokinetic Principles: Interpreting Bisphenol A Absorption in the Canine Oral Cavity
Justin G. Teeguarden,1 Jeffrey W. Fisher,2 Daniel R. Doerge2
1Pacific Northwest National Laboratory, Richland, Washington, USA; 2National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA, E-mail: firstname.lastname@example.org
Citation: Teeguarden JG, Fisher JW, Doerge DR. 2013. Exposure conditions and pharmacokinetic principles: interpreting bisphenol A absorption in the canine oral cavity [Letter]. Environ Health Perspect 121:A323; http://dx.doi.org/10.1289/ehp.1307424
J.G.T. has received grants from the U.S. Environmental Protection Agency, the National Institute for Occupational Safety and Health, and the American Chemistry Council. J.W.F. and D.R.D. declare they have no actual or potential competing financial interests.
Published: 27 November 2013
Gayrard et al. (2013) reported significant (~ 80%) absorption of bisphenol A (BPA) from solutions applied to the oral cavity of dogs, leading to higher serum BPA (aglycone) concentrations than occurred when BPA was absorbed through the gastrointestinal tract. This finding is consistent with first principles and experience with orally absorbed drugs. The implications for human exposure and health will be clear when experimental evidence is available regarding the extent and frequency of sublingual absorption in orally exposed humans.
Arguments made by Gayrard et al. that “nanograms-per-milliliter” serum concentrations of BPA resulting from sublingual absorption are plausible in humans ignore key pharmacokinetic and exposure data and conflate issues of serum BPA concentrations with serum BPA/BPAG (BPA glucuronide) ratios.
For a given dose, bolus dosing yields peak concentrations of a parent compound that are higher than those with nonbolus dosing. Peak concentrations in mixed systemic serum following sublingual exposure cannot exceed those following intraveneous (iv) dosing. Therefore, in humans, peak systemic serum concentrations following sublingual exposure cannot be higher than those resulting from bolus iv administration of a given BPA dose. Scaling by dose from pharmacokinetic studies of nonhuman primates (Patterson et al. 2013), the human serum concentration of aglycone BPA immediately after an iv bolus administration of a dose equivalent to a 95th percentile of aggregate daily U.S. human exposure (0.22 μg/kg body weight; Lakind and Naiman 2010) would be < 0.1 ng/mL, which is below current quantification limits (LOQ) using state-of-the-art technology. Therefore, peak systemic serum concentrations of aglycone BPA following sublingual exposure/absorption of this dose would also be < LOQ. This result is consistent with the data of Gayrard et al. (2013) in which dog serum BPA concentrations would be ~ 0.07 ng/mL (i.e., < LOQ) when sampled from a site reflecting systemic exposure (e.g., leg vein). Therefore, in 95% of the U.S. population, serum aglycone BPA concentrations of nanograms per milliliter are not possible, even with complete sublingual absorption.
Several studies in the literature have reported BPA/BPAG ratios in human serum samples higher than those (< 1%) consistently observed in human and animal oral pharmacokinetic studies (Vandenberg et al. 2007). Gayrard et al. (2013) introduced a new hypothesis (i.e., sublingual exposure/absorption) to justify this discrepancy. Previously proffered hypotheses for high BPA and BPA/BPAG ratios in human serum samples included exposures 10, 000 times higher (Vandenberg et al. 2007) than those measured in humans (Lakind and Naiman 2010), extensive dermal exposure/absorption (Vandenberg et al. 2013), and sample contamination (Teeguarden et al. 2011). Only the latter hypothesis is supported by ample evidence that contamination of blood samples is not only common, but difficult to avoid (Ye et al. 2013).
Finally, extrapolation of BPA levels from BPAG levels using the measured ratio of < 1% following ingestion of BPA is appropriate under conditions where BPA reaches the systemic blood via gastrointestinal tract absorption [e.g., food (see Teeguarden et al. 2011)]. Similarly, values of approximately 10–20% would be valid for serum levels 0–4 hr after iv dosing or complete sublingual absorption, when sampled from a site representing systemic exposure.
Gayrard V, Lacroix MZ, Collet SH, Viguié C, Bousquet-Melou A, Toutain PL, et al. 2013. High bioavailability of bisphenol A from sublingual exposure. Environ Health Perspect 121:951–956; doi:10.1289/ehp.1206339.
Patterson TA, Twaddle NC, Roegge CS, Callicott RJ, Fisher JW, Doerge DR. 2013. Concurrent determination of bisphenol A pharmacokinetics in maternal and fetal rhesus monkeys. Toxicol Appl Pharmacol 267:41–48.
Ye X, Zhou X, Hennings R, Kramer J, Calafat AM. 2013. Potential external contamination with bisphenol A and other ubiquitous organic environmental chemicals during biomonitoring analysis: an elusive laboratory challenge. Environ Health Perspect 121:283–286; doi:10.1289/ ehp.1206093.
Introducing Children’s Health Collection 2014
EHP’s fifth annual Children’s Health Collection is now available. The collection comprises abstracts of all relevant articles published in EHP from October 2013 through September 2014: peer-reviewed research articles, news features, Science Selections, and editorials.
Now Recruiting—EHP Operations Manager
The NIEHS Office of the Deputy Director is now recruiting for a Supervisory Technical Editor (Operations Manager) for EHP. As deputy to the Editor-in-Chief of EHP, the Operations Manager will be responsible for overall journal operations. The position closes Thursday, 20 November 2014. Visit our Careers and Funding page for more details.
ISEE 2014 Abstracts Now Available
EHP is pleased to present the abstracts for the 26th annual conference of the International Society for Environmental Epidemiology (ISEE), From Local to Global: Advancing Science for Policy in Environmental Health, held 24–28 August 2014 in Seattle, Washington.
CEHN November 2014 Article of the Month
“Asthma in Inner-City Children at 5–11 Years of Age and Prenatal Exposure to Phthalates: The Columbia Center for Children’s Environmental Health Cohort” (Environ Health Perspect; DOI:10.1289/ehp.1307670) has been selected by the Children’s Environmental Health Network (CEHN) as its November 2014 Article of the Month. These CEHN summaries discuss the potential policy implications of current children’s environmental health research.
Sign Up to Receive E-mail Alerts
Recent Advance Publications
Global Analysis of Posttranscriptional Gene Expression in Response to Sodium Arsenite
Exposure to Free and Conjugated Forms of Bisphenol A and Triclosan among Pregnant Women in the MIREC Cohort
Associations of Plasma Concentrations of Dichlorodiphenyldichloroethylene and Polychlorinated Biphenyls with Prostate Cancer: A Case–Control Study in Guadeloupe (French West Indies)
Urinary Phthalate Metabolites and Biomarkers of Oxidative Stress in Pregnant Women: A Repeated Measures Analysis
A Unified Spatiotemporal Modeling Approach for Predicting Concentrations of Multiple Air Pollutants in the Multi-Ethnic Study of Atherosclerosis and Air Pollution